Subjective symptoms are triggers for the detection of immune checkpoint inhibitor-induced interstitial lung disease and associate with disease severity: a single-center retrospective study

Table 2 Severity of ICI-ILD

	Grade 1–2 (n = 30)	Grade 3–5 (n = 21)	P value
Lung cancer patients	21 (56.8)	16 (43.2)	0.754
Other cancer patients	9 (64.3)	5 (35.7)	0.754

Fisher’s exact test was used. ICI-ILD, immune checkpoint inhibitor -induced interstitial lung disease; ILD, interstitial lung disease

ISSN: 2055-0294